Imatinib Mesylate 62135-0658
Product NDC
62135-0658- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 17, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA208429
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 100 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(1)
90 TABLET, FILM COATED in 1 BOTTLE (62135-658-90)